{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:58:21Z","timestamp":1790956701355,"version":"4.1.0"},"reference-count":130,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:p>The endocrine system influences all tissues and cells in the human body. The ocular surface is constantly exposed to circulating hormones and expresses their specific receptors. Dry eye disease (DED) is a disorder with multifactorial etiology, and endocrine anomalies are one of the inciting factors. The endocrine anomalies that cause DED include physiological conditions such as menopause, menstrual cycle variations, pathologies such as polycystic ovarian syndrome, androgen resistance, iatrogenic conditions such as contraceptive use, and antiandrogen treatment. This review highlights the status of these hormones in DED along with the mechanism of action of different hormones on the ocular surface structures and the clinical implications of these effects. The influence of androgens, estrogens, and progesterone on the ocular surface tissues, and the implications of androgen-deficient states in DED are also discussed. The physiological and pathological effects of menopause and sex hormone replacement therapy are discussed. The effects of insulin and insulin resistance on the ocular surface and DED, and the growing potential of topical insulin therapeutics for DED are mentioned. Thyroid-associated ophthalmopathy, its impact on the ocular surface, and the tissue effects of thyroid hormone in the context of DED are reviewed. Finally, the potential role of hormonal therapeutics in the management of DED has also been discussed. The compelling evidence suggests that it would be clinically beneficial to consider the possibility of hormonal imbalances and their impact while treating patients with DED.<\/jats:p>","DOI":"10.4103\/ijo.ijo_2887_22","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T11:10:52Z","timestamp":1680952252000},"page":"1276-1284","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":78,"title":["Hormones and dry eye disease"],"prefix":"10.4103","volume":"71","author":[{"given":"Bhavya","family":"Gorimanipalli","sequence":"first","affiliation":[{"name":"Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Khamar","sequence":"additional","affiliation":[{"name":"Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaminathan","family":"Sethu","sequence":"additional","affiliation":[{"name":"GROW Research Laboratory, Narayana Nethralaya Foundation, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Shetty","sequence":"additional","affiliation":[{"name":"Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1755-3768.1983.tb01401.x","article-title":"Ocular surface drying and tear film osmolarity in thyroid eye disease","volume":"61","author":"Gilbard","year":"2009","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ajo.2007.01.030","article-title":"Itchy-dry eye associated with polycystic ovary syndrome","volume":"143","author":"Bonini","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1167\/iovs.07-0770","article-title":"The ocular surface:The challenge to enable and protect vision:The Friedenwald lecture","volume":"48","author":"Gipson","year":"2007","journal-title":"Investig Opthalmology Vis Sci"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.physbeh.2017.08.012","article-title":"Applying the new SABV (sex as a biological variable) policy to research and clinical care","volume":"187","author":"Clayton","year":"2018","journal-title":"Physiol Behav"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/ceo.12183","article-title":"Prevalence of dry eye syndrome in an adult population","volume":"42","author":"Hashemi","year":"2014","journal-title":"Clin Experiment Ophthalmol"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0002-9394(03)00218-6","article-title":"Prevalence of dry eye syndrome among US women","volume":"136","author":"Schaumberg","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archophthalmol.2009.103","article-title":"Prevalence of dry eye disease among US Men:Estimates from the physicians'health studies","volume":"127","author":"Schaumberg","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1442-9071.2003.00634.x","article-title":"Prevalence and associations of dry eye syndrome in an older population:The Blue Mountains Eye Study","volume":"31","author":"Chia","year":"2003","journal-title":"Clin Exp Ophthalmol"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/ICL.0b013e31815eb0c9","article-title":"Ocular discomfort from pterygium in men and women","volume":"34","author":"Wilson","year":"2008","journal-title":"Eye Contact Lens Sci Clin Pract"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1749-6632.1999.tb07656.x","article-title":"Androgens and dry eye in Sj\u00f6gren's syndromea","volume":"876","author":"Sullivan","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"R12-20240828","first-page":"7733","article-title":"Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sj\u00f6gren's syndrome mouse model","volume":"34","author":"Parashar","year":"2020","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The androgen excess and PCOS society criteria for the polycystic ovary syndrome:The complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4274\/tjo.73659","article-title":"Anterior segment findings in women with polycystic ovary syndrome","volume":"47","author":"Karaca","year":"2017","journal-title":"Turk J Ophthalmol"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00404-014-3353-y","article-title":"Cornea in PCOS patients as a possible target of IGF-1 action and insulin resistance","volume":"290","author":"Kebapcilar","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1210\/jcem-50-2-246","article-title":"Differences in insulin receptors between men and menstruating women and influence of sex hormones on insulin binding during the menstrual cycle","volume":"50","author":"Bertoli","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-20240828","first-page":"548","article-title":"[Neuronal and hormonal regulatory mechanisms of tears production and secretion","volume":"107","author":"Mrugacz","year":"2005","journal-title":"Klin Oczna"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.ico.0000183664.80004.44","article-title":"Identification of steroidogenic enzyme mrnas in the human lacrimal gland, meibomian gland, cornea, and conjunctiva","volume":"25","author":"Schirra","year":"2006","journal-title":"Cornea"},{"key":"R20-20240828","first-page":"1553","article-title":"Do sex steroids exert sex-specific and\/or opposite effects on gene expression in lacrimal and meibomian glands?","volume":"15","author":"Sullivan","year":"2009","journal-title":"Mol Vis"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1167\/iovs.05-0426","article-title":"Androgen control of gene expression in the mouse meibomian gland","volume":"46","author":"Schirra","year":"2005","journal-title":"Investig Opthalmol Vis Sci"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/archopht.120.12.1689","article-title":"Complete androgen insensitivity syndrome:Effect on human meibomian gland secretions","volume":"120","author":"Sullivan","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00003226-200308000-00006","article-title":"Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface?","volume":"22","author":"Cermak","year":"2003","journal-title":"Cornea"},{"key":"R25-20240828","first-page":"4874","article-title":"Effect of androgen deficiency on the human meibomian gland and ocular surface","volume":"85","author":"Krenzer","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-20240828","first-page":"4866","article-title":"Impact of antiandrogen treatment on the fatty acid profile of neutral lipids in human meibomian gland secretions","volume":"85","author":"Sullivan","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1749-6632.2002.tb04217.x","article-title":"Androgen deficiency, meibomian gland dysfunction, and evaporative dry eye","volume":"966","author":"Sullivan","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"R28-20240828","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jsbmb.2005.04.037","article-title":"Androgen regulation of gene expression in the mouse lacrimal gland","volume":"96","author":"Richards","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R29-20240828","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1542-0124(12)70147-7","article-title":"Tearful relationships?Sex, hormones, the lacrimal gland, and aqueous-deficient dry eye","volume":"2","author":"Sullivan","year":"2004","journal-title":"Ocul Surf"},{"key":"R30-20240828","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0022-4731(89)90089-7","article-title":"Hormonal influence on the secretory immune system of the eye:Endocrine impact on the lacrimal gland accumulation and secretion of IgA and IgG","volume":"34","author":"Sullivan","year":"1989","journal-title":"J Steroid Biochem"},{"key":"R31-20240828","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/cells11020224","article-title":"Sex hormones, growth hormone, and the cornea","volume":"11","author":"McKay","year":"2022","journal-title":"Cells"},{"key":"R32-20240828","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1076\/ceyr.22.1.28.6980","article-title":"Expression of sex steroid hormone receptors in human cornea","volume":"22","author":"Suzuki","year":"2001","journal-title":"Curr Eye Res"},{"key":"R33-20240828","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1167\/iovs.07-1458","article-title":"Estrogen and progesterone control of gene expression in the mouse meibomian gland","volume":"49","author":"Suzuki","year":"2008","journal-title":"Investig Opthalmology Vis Sci"},{"key":"R34-20240828","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/1523-1747.ep12676783","article-title":"Endocrinologic control to the development and activity of the human sebaceous gland","volume":"62","author":"Pochi","year":"1974","journal-title":"J Invest Dermatol"},{"key":"R35-20240828","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00404289","article-title":"Influence of cyproterone acetate and estradiol on cell kinetics in the sebaceous gland of the golden hamster ear","volume":"268","author":"Wirth","year":"1980","journal-title":"Arch Dermatol Res"},{"key":"R36-20240828","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/jid.1962.94","article-title":"The effect of androgens and estrogens on human sebaceous glands","volume":"39","author":"Strauss","year":"1962","journal-title":"J Invest Dermatol"},{"key":"R37-20240828","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF00404322","article-title":"The effect of estradiol on the sebaceous gland of the hamster ear and its antagonism by tamoxifen","volume":"277","author":"Sch\u00e4fer","year":"1985","journal-title":"Arch Dermatol Res"},{"key":"R38-20240828","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.286.17.2114","article-title":"Hormone replacement therapy and dry eye syndrome","volume":"286","author":"Schaumberg","year":"2001","journal-title":"JAMA"},{"key":"R39-20240828","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.maturitas.2006.08.007","article-title":"Dry eye in post-menopausal women using hormone replacement therapy","volume":"56","author":"Erdem","year":"2007","journal-title":"Maturitas"},{"key":"R40-20240828","first-page":"177","article-title":"[The influence of the hormonal replacement therapy on the amount and stability of the tear film among peri- and postmenopausal women]","volume":"103","author":"Oko\u0144","year":"2001","journal-title":"Klin Oczna"},{"key":"R41-20240828","doi-asserted-by":"crossref","first-page":"e76121","DOI":"10.1371\/journal.pone.0076121","article-title":"Patient reported differences in dry eye disease between men and women:Impact, management, and patient satisfaction","volume":"8","author":"Schaumberg","year":"2013","journal-title":"PLoS One"},{"key":"R42-20240828","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/GME.0000000000000530","article-title":"Dry eye in postmenopausal women:A hormonal disorder","volume":"23","author":"Sriprasert","year":"2016","journal-title":"Menopause"},{"key":"R43-20240828","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.exer.2014.07.017","article-title":"Does estrogen deficiency cause lacrimal gland inflammation and aqueous-deficient dry eye in mice?","volume":"127","author":"Rahimi","year":"2014","journal-title":"Exp Eye Res"},{"key":"R44-20240828","first-page":"1466","article-title":"Hypothesis for an indirect role of estrogens in maintaining lacrimal gland-function","author":"Azzarolo","journal-title":"In lippincott-raven publ 227 east washington sq, Philadelphia, PA;1993."},{"key":"R46-20240828","doi-asserted-by":"crossref","first-page":"e0121470","DOI":"10.1371\/journal.pone.0121470","article-title":"A comparison of the effects of estrogen and cimicifuga racemosa on the lacrimal gland and submandibular gland in ovariectomized rats","volume":"10","author":"Da","year":"2015","journal-title":"PLoS One"},{"issue":"Suppl","key":"R47-20240828","first-page":"25","article-title":"The effect of oophorectomy on the rabbit lacrimal system","volume":"27","author":"Jacobs","year":"1986","journal-title":"Invest Ophthalmol Vis Sci Suppl"},{"key":"R48-20240828","doi-asserted-by":"crossref","first-page":"C113","DOI":"10.1016\/0303-7207(91)90116-A","article-title":"Intracrinology","volume":"78","author":"Labrie","year":"1991","journal-title":"Mol Cell Endocrinol"},{"key":"R49-20240828","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.1995.tb17369.x","article-title":"DHEA and peripheral androgen and estrogen formation:Intracrinology","volume":"774","author":"Labrie","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"R50-20240828","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jsbmb.2014.06.001","article-title":"All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause","volume":"145","author":"Labrie","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R51-20240828","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/bjophthalmol-2017-310610","article-title":"Local synthesis of sex hormones:Are there consequences for the ocular surface and dry eye?","volume":"101","author":"Gibson","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"R52-20240828","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3109\/00016349509021200","article-title":"Conjunctiva is an estrogen-sensitive epithelium","volume":"74","author":"Vavilis","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R53-20240828","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.ico.0000244873.08127.3c","article-title":"Variations in central corneal thickness during the menstrual cycle in women","volume":"26","author":"Giuffr\u00e8","year":"2007","journal-title":"Cornea"},{"key":"R54-20240828","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jcrs.2011.03.038","article-title":"Variations in corneal biomechanical parameters and central corneal thickness during the menstrual cycle","volume":"37","author":"Goldich","year":"2011","journal-title":"J Cataract Refract Surg"},{"key":"R55-20240828","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/bjo.66.2.123","article-title":"Corneal sensitivity during the menstrual cycle","volume":"66","author":"Riss","year":"1982","journal-title":"Br J Ophthalmol"},{"key":"R56-20240828","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/09513590701350390","article-title":"Ocular surface changes over the menstrual cycle in women with and without dry eye","volume":"23","author":"Versura","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"R57-20240828","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jtos.2019.06.005","article-title":"Daily fluctuations in ocular surface symptoms during the normal menstrual cycle and with the use of oral contraceptives","volume":"17","author":"Boga","year":"2019","journal-title":"Ocul Surf"},{"key":"R58-20240828","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.clae.2013.11.005","article-title":"Changes in tear film, corneal topography, and refractive status in premenopausal women during menstrual cycle","volume":"37","author":"Cavdar","year":"2014","journal-title":"Contact Lens Anterior Eye"},{"key":"R59-20240828","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/01.ico.0000160973.04072.a5","article-title":"Estrogen stimulation of proinflammatory cytokine and matrix metalloproteinase gene expression in human corneal epithelial cells","volume":"24","author":"Suzuki","year":"2005","journal-title":"Cornea"},{"key":"R60-20240828","first-page":"1115","article-title":"17-\u03b2-estradiol inhibits hyperosmolarity-induced proinflammatory cytokine elevation via the p38 MAPK pathway in human corneal epithelial cells","volume":"18","author":"Wang","year":"2012","journal-title":"Mol Vis"},{"key":"R61-20240828","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1034\/j.1600-0897.2002.01061.x","article-title":"Cytokine changes in postmenopausal women treated with estrogens:A placebo-controlled study","volume":"48","author":"Berg","year":"2002","journal-title":"Am J Reprod Immunol"},{"key":"R62-20240828","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00011-007-6198-z","article-title":"Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytes","volume":"56","author":"Nilsson","year":"2007","journal-title":"Inflamm Res"},{"key":"R63-20240828","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/cyto.1999.0570","article-title":"Influence of the menstrual cycle on the LPS-induced cytokine response of monocytes","volume":"12","author":"Schwarz","year":"2000","journal-title":"Cytokine"},{"key":"R64-20240828","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/oxfordjournals.humrep.a137829","article-title":"Cytokine expression in human endometrium throughout the menstrual cycle","volume":"7","author":"Tabibzadeh","year":"1992","journal-title":"Hum Reprod"},{"key":"R65-20240828","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2152\/jmi.59.12","article-title":"Androgen in postmenopausal women","volume":"59","author":"Yasui","year":"2012","journal-title":"J Med Invest"},{"key":"R66-20240828","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/bjophthalmol-2016-308473","article-title":"Does endogenous serum oestrogen play a role in meibomian gland dysfunction in postmenopausal women with dry eye?","volume":"101","author":"Golebiowski","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"R67-20240828","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/bjophthalmol-2012-302705","article-title":"Low levels of 17-\u03b2-oestradiol, oestrone and testosterone correlate with severe evaporative dysfunctional tear syndrome in postmenopausal women:A case-control study","volume":"98","author":"Gagliano","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"R68-20240828","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/09513590600917919","article-title":"The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity","volume":"22","author":"Uncu","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"R69-20240828","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/01.GME.0000063568.84134.35","article-title":"Effects of hormone replacement therapy on ocular function in postmenopause","volume":"10","author":"Affinito","year":"2003","journal-title":"Menopause"},{"key":"R70-20240828","first-page":"44","article-title":"A survey of ocular complaints in postmenopausal women","volume":"11","author":"Jensen","year":"2000","journal-title":"J Assoc Acad Minor Phys"},{"key":"R71-20240828","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1755-3768.1992.tb08576.x","article-title":"Tear film profile in Graves'ophthalmopathy","volume":"70","author":"Khurana","year":"2009","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"R72-20240828","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12886-018-0763-9","article-title":"The function and morphology of Meibomian glands in patients with thyroid eye disease:A preliminary study","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"R73-20240828","doi-asserted-by":"crossref","first-page":"e800","DOI":"10.1111\/aos.14000","article-title":"Dry eye syndrome in thyroid eye disease patients:The role of increased incomplete blinking and Meibomian gland loss","volume":"97","author":"Park","year":"2019","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"R74-20240828","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jcjo.2017.11.006","article-title":"Functional and structural evaluation of the meibomian gland using a LipiView interferometer in thyroid eye disease","volume":"53","author":"Park","year":"2018","journal-title":"Can J Ophthalmol"},{"key":"R75-20240828","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jcjo.2015.05.012","article-title":"Meibomian gland dysfunction in Graves'orbitopathy","volume":"50","author":"Kim","year":"2015","journal-title":"Can J Ophthalmol"},{"key":"R76-20240828","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0161-6420(81)34993-8","article-title":"Correlation of CT scanning and pathologic features of ophthalmic Graves'disease","volume":"88","author":"Trokel","year":"1981","journal-title":"Ophthalmology"},{"key":"R77-20240828","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2265.1990.tb00897.x","article-title":"Correlation of orbital computed tomography and antibodies in patients with hyperthyroid Graves'disease","volume":"32","author":"Chang","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R78-20240828","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1167\/iovs.13-13704","article-title":"Changes of lacrimal gland and tear inflammatory cytokines in thyroid-associated ophthalmopathy","volume":"55","author":"Huang","year":"2014","journal-title":"Investig Opthalmology Vis Sci"},{"key":"R79-20240828","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/IOP.0000000000000015","article-title":"Calculated computed tomography volumes of lacrimal glands and comparison to clinical findings in patients with thyroid eye disease","volume":"30","author":"Bingham","year":"2014","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R80-20240828","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1089\/thy.2021.0671","article-title":"Immunophenotype of lacrimal glands in graves orbitopathy:Implications for the pathogenesis of Th1 and Th17 immunity","volume":"32","author":"Huang","year":"2022","journal-title":"Thyroid"},{"key":"R81-20240828","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1395-3907.2004.00268.x","article-title":"Dry eye syndrome in thyroid-associated ophthalmopathy:Lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies","volume":"82","author":"Eckstein","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"key":"R82-20240828","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1167\/iovs.06-1309","article-title":"Influence of thyroid hormone on thyroid hormone receptor b-1 expression and lacrimal gland and ocular surface morphology","volume":"48","author":"Dias","year":"2007","journal-title":"Investig Opthalmol Vis Sci"},{"key":"R83-20240828","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ajo.2008.12.007","article-title":"Occult thyroid eye disease in patients presenting with dry eye symptoms","volume":"147","author":"Gupta","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R84-20240828","first-page":"12","article-title":"Efficacy and toxicity of radiotherapy for Graves'ophthalmopathy:The University of Athens experience","volume":"5","author":"Kouloulias","year":"2013","journal-title":"Head Neck Oncol"},{"key":"R85-20240828","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1748-717X-7-95","article-title":"Clinical outcomes of radiotherapy as initial local therapy for Graves'ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery","volume":"7","author":"Prabhu","year":"2012","journal-title":"Radiat Oncol"},{"key":"R86-20240828","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijrobp.2010.08.053","article-title":"The efficacy of radiation therapy in the treatment of Graves'orbitopathy","volume":"82","author":"Matthiesen","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"R87-20240828","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1076\/orbi.21.1.19.2602","article-title":"Risk of dry eye after mullerectomy via the posterior conjunctival approach for thyroid-related upper eyelid retraction","volume":"21","author":"George","year":"2002","journal-title":"Orbit"},{"key":"R88-20240828","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/ICO.0b013e318165b19e","article-title":"Effects of osmoprotectants on hyperosmolar stress in cultured human corneal epithelial cells","volume":"27","author":"Corrales","year":"2008","journal-title":"Cornea"},{"key":"R89-20240828","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3109\/02713683.2010.490320","article-title":"Topical cyclosporine in thyroid orbitopathy-related dry eye:Clinical findings, conjunctival epithelial apoptosis, and MMP-9 expression","volume":"35","author":"G\u00fcrdal","year":"2010","journal-title":"Curr Eye Res"},{"key":"R90-20240828","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0021-9258(18)85783-0","article-title":"Studies on experimental rickets","volume":"53","author":"McCollum","year":"1922","journal-title":"J Biol Chem"},{"key":"R91-20240828","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nrd3318","article-title":"Vitamin D, disease and therapeutic opportunities","volume":"9","author":"Plum","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"R92-20240828","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1359\/JBMR.041112","article-title":"1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor\/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts","volume":"20","author":"Kim","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R93-20240828","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1167\/iovs.19-26914","article-title":"Dysregulated tear fluid nociception-associated factors, corneal dendritic cell density, and vitamin D levels in evaporative dry eye","volume":"60","author":"Khamar","year":"2019","journal-title":"Investig Opthalmology Vis Sci"},{"key":"R94-20240828","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/cts.12858","article-title":"Genistein-calcitriol mitigates hyperosmotic stress-induced TonEBP, CFTR dysfunction, VDR degradation and inflammation in dry eye disease","volume":"14","author":"Panigrahi","year":"2021","journal-title":"Clin Transl Sci"},{"key":"R95-20240828","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1167\/iovs.11-7605","article-title":"Vitamin D enhances corneal epithelial barrier function","volume":"52","author":"Yin","year":"2011","journal-title":"Investig Opthalmol Vis Sci"},{"key":"R96-20240828","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.1167\/iovs.15-17768","article-title":"Vitamin D activation and function in human corneal epithelial cells during TLR-induced inflammation","volume":"56","author":"Reins","year":"2015","journal-title":"Investig Opthalmol Vis Sci"},{"key":"R97-20240828","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/08820538.2017.1358752","article-title":"Vitamin D replacement improves tear osmolarity in patients with vitamin D deficiency","volume":"33","author":"Kizilgul","year":"2018","journal-title":"Semin Ophthalmol"},{"key":"R98-20240828","doi-asserted-by":"crossref","first-page":"33083","DOI":"10.1038\/srep33083","article-title":"Vitamin D supplementation for patients with dry eye syndrome refractory to conventional treatment","volume":"6","author":"Bae","year":"2016","journal-title":"Sci Rep"},{"key":"R99-20240828","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000354965","article-title":"Putative corneal neuralgia responding to vitamin D supplementation","volume":"4","author":"Singman","year":"2013","journal-title":"Case Rep Ophthalmol"},{"key":"R100-20240828","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/ICO.0000000000001822","article-title":"Vitamin D enhances the efficacy of topical artificial tears in patients with dry eye disease","volume":"38","author":"Hwang","year":"2019","journal-title":"Cornea"},{"key":"R101-20240828","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/bjo.84.1.19","article-title":"Tear secretion and tear film function in insulin dependent diabetics","volume":"84","author":"Goebbels","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"R102-20240828","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1080\/02713683.2019.1641827","article-title":"Dry eye disease is more prevalent in children with diabetes than in those without diabetes","volume":"44","author":"Wang","year":"2019","journal-title":"Curr Eye Res"},{"key":"R103-20240828","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jdiacomp.2013.04.006","article-title":"Dry eye and its correlation to diabetes microvascular complications in people with type 2 diabetes mellitus","volume":"27","author":"Najafi","year":"2013","journal-title":"J Diabetes Complications"},{"key":"R104-20240828","doi-asserted-by":"crossref","first-page":"158","DOI":"10.5935\/0004-2749.20150041","article-title":"Insulin replacement restores the vesicular secretory apparatus in the diabetic rat lacrimal gland","volume":"78","author":"Dias","year":"2015","journal-title":"Arq Bras Oftalmol"},{"key":"R105-20240828","first-page":"2610","article-title":"Influence of culture conditions on the androgen control of secretory component production by acinar cells from the rat lacrimal gland","volume":"32","author":"Hann","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R106-20240828","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1007\/s00125-005-0010-9","article-title":"Increased expression of advanced glycation end-products and their receptor, and activation of nuclear factor kappa-B in lacrimal glands of diabetic rats","volume":"48","author":"Alves","year":"2005","journal-title":"Diabetologia"},{"key":"R107-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2019.04.014","article-title":"Prospective insulin-based ophthalmic delivery systems for the treatment of dry eye syndrome and corneal injuries","volume":"140","author":"Cruz-Cazarim","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"R108-20240828","doi-asserted-by":"crossref","first-page":"e94913","DOI":"10.1371\/journal.pone.0094913","article-title":"Cortisol biosynthesis in the human ocular surface innate immune response","volume":"9","author":"Susarla","year":"2014","journal-title":"PLoS One"},{"key":"R109-20240828","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2203\/dose-response.10-013.Yeager","article-title":"Cortisol exerts bi-phasic regulation of inflammation in humans","volume":"9","author":"Yeager","year":"2011","journal-title":"Dose Response"},{"key":"R110-20240828","doi-asserted-by":"crossref","first-page":"ra74","DOI":"10.1126\/scisignal.2001077","article-title":"Sexually dimorphic actions of glucocorticoids provide a link to inflammatory diseases with gender differences in prevalence","volume":"3","author":"Duma","year":"2010","journal-title":"Sci Signal"},{"key":"R111-20240828","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0002-9343(93)90360-2","article-title":"Prolactin and immunomodulation","volume":"95","author":"Reber","year":"1993","journal-title":"Am J Med"},{"key":"R112-20240828","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.4049\/jimmunol.147.11.3780","article-title":"Prolactin influences autoimmune disease activity in the female B\/W mouse","volume":"147","author":"McMurray","year":"1991","journal-title":"J Immunol"},{"key":"R113-20240828","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.tripleo.2003.10.033","article-title":"A comparison of the hormone levels in patients with Sjogren's syndrome and healthy controls","volume":"97","author":"Taiym","year":"2004","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R114-20240828","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00003226-199807000-00002","article-title":"Menopause and tear function:The influence of prolactin and sex hormones on human tear production","volume":"17","author":"Mathers","year":"1998","journal-title":"Cornea"},{"key":"R115-20240828","first-page":"1","article-title":"Growth hormone influence on the morphology and size of the mouse meibomian gland","volume":"2016","author":"Liu","year":"2016","journal-title":"J Ophthalmol"},{"key":"R116-20240828","first-page":"40","article-title":"The efficacy of androgenic artificial tears in the treatment of dry eye","volume":"3","author":"Connor"},{"key":"R117-20240828","first-page":"5608","article-title":"A multi-center, double-masked, randomized, vehicle-controlled, parallel group study to evaluate the safety and efficacy of testosterone ophthalmic solution in patients with meibomian gland dysfunction","volume":"47","author":"Schiffman","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R118-20240828","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0378-5122(00)00181-X","article-title":"Treatment of keratoconjunctivitis sicca with topical androgen","volume":"37","author":"Worda","year":"2001","journal-title":"Maturitas"},{"key":"R119-20240828","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1471-0528.1998.tb09358.x","article-title":"Treatment of menopausal keratoconjunctivitis sicca with topical oestradiol","volume":"105","author":"Sator","year":"1998","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"R121-20240828","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1067\/S0002-9378(03)00366-1","article-title":"The treatment of Sj\u00f6gren's syndrome with tibolone:A case report","volume":"189","author":"Sartore","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R123-20240828","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3390\/jcm11061518","article-title":"Comparison of trehalose\/hyaluronic acid (HA) vs. 0.001% hydrocortisone\/HA Eyedrops on signs and inflammatory markers in a desiccating model of dry eye disease (DED)","volume":"11","author":"Astolfi","year":"2022","journal-title":"J Clin Med"},{"key":"R124-20240828","doi-asserted-by":"crossref","first-page":"e7584370","DOI":"10.1155\/2021\/7584370","article-title":"Efficacy of topical hydrocortisone in combination with topical ciclosporin A for the treatment of dry eye disease in patients with Sj\u00f6gren syndrome","volume":"2021","author":"Fondi","year":"2021","journal-title":"J Ophthalmol"},{"key":"R125-20240828","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12325-019-01137-8","article-title":"Topical low dose preservative-free hydrocortisone reduces signs and symptoms in patients with chronic dry eye:A randomized clinical trial","volume":"37","author":"Kallab","year":"2020","journal-title":"Adv Ther"},{"key":"R126-20240828","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.2147\/OPTH.S283655","article-title":"A retrospective data review confirms that topical preservative-free hydrocortisone improves inflammation in dry eye disease","volume":"14","author":"Kuzmanovi\u0107Elabjer","year":"2020","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"R127-20240828","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3389\/fphar.2019.01240","article-title":"Ocular pharmacological profile of hydrocortisone in dry eye disease","volume":"10","author":"Bucolo","year":"2019","journal-title":"Front Pharmacol"},{"key":"R128-20240828","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41433-021-01517-x","article-title":"Effects of hormonal contraceptives on dry eye disease:A population-based study","volume":"36","author":"He","year":"2022","journal-title":"Eye"},{"key":"R129-20240828","doi-asserted-by":"crossref","first-page":"263","DOI":"10.18231\/2395-1451.2018.0058","article-title":"Dry eye syndrome in reproductive age group women on oral contraceptives","volume":"4","author":"Tyagi","year":"2020","journal-title":"Indian J Clin Exp Ophthalmol"},{"key":"R130-20240828","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0275-5408(00)00005-3","article-title":"Effect of oral contraceptives on tear physiology","volume":"21","author":"Tomlinson","year":"2001","journal-title":"Ophthalmic Physiol Opt"},{"key":"R131-20240828","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/ICO.0b013e3182662390","article-title":"Tear osmolarity and dry eye symptoms in women using oral contraception and contact lenses","volume":"32","author":"Chen","year":"2013","journal-title":"Cornea"},{"key":"R132-20240828","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.optom.2012.08.006","article-title":"Tear secretion and tear stability of women on hormonal contraceptives","volume":"6","author":"Kemdinum","year":"2013","journal-title":"J Optom"},{"key":"R133-20240828","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.breast.2015.08.008","article-title":"Dry eyes and AIs:If you don't ask you won't find out","volume":"24","author":"Inglis","year":"2015","journal-title":"Breast"},{"key":"R134-20240828","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1442-9071.2012.02865.x","article-title":"Dry eye syndrome in aromatase inhibitor users","volume":"41","author":"Turaka","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"R135-20240828","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jtos.2019.10.008","article-title":"Dry eye signs and symptoms in aromatase inhibitor treatment and the relationship with pain","volume":"18","author":"Gibson","year":"2020","journal-title":"Ocul Surf"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_2887_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:13:18Z","timestamp":1787166798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_2887_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":130,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_2887_22","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"2022-10-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}